SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets close in 2 hrs 41 mins

Sanofi (SNY)


NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
45.89+1.80 (+4.09%)
As of 1:17PM EDT. Market open.
People also watch
NVSGSKAZNLLYNVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close44.09
Open46.11
Bid0.00 x
Ask0.00 x
Day's Range45.72 - 46.16
52 Week Range36.81 - 46.16
Volume3,285,964
Avg. Volume1,483,754
Market Cap114.61B
Beta0.75
PE Ratio (TTM)23.74
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.58 (3.46%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Mylan Tried to `Squelch' EpiPen Rival, Sanofi Says in Lawsuit
    Bloomberg25 minutes ago

    Mylan Tried to `Squelch' EpiPen Rival, Sanofi Says in Lawsuit

    Mylan NV was accused by French drugmaker Sanofi of using anti-competitive tactics to block the introduction of a competitor to Mylan’s EpiPen allergy treatment and artificially inflate the price of the ...

  • TheStreet.com58 minutes ago

    Sanofi Sues Mylan Over EpiPen Practices

    French multinational pharmaceutical company Sanofi on Monday filed a lawsuit against U.S. company Mylan.

  • Reuters1 hour ago

    Sanofi files U.S. antitrust lawsuit against Mylan over EpiPen

    France's Sanofi SA on Monday sued Mylan NV, accusing the pharmaceutical company of engaging in illegal conduct to squelch competition to its EpiPen allergy treatment, which has been at the center of a public debate over drug prices. In a lawsuit filed in federal court in Trenton, New Jersey, Sanofi said Mylan caused it to lose hundreds of millions of dollars in sales by erecting barriers to U.S. consumers' access to and use of a rival product, Auvi-Q.